Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Day One Biopharmaceuticals (DAWN) Revenue (2024 - 2025)

Historic Revenue for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Q3 2025 value amounting to $39.8 million.

  • Day One Biopharmaceuticals' Revenue fell 5755.7% to $39.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $133.7 million, marking a year-over-year increase of 3111.14%. This contributed to the annual value of $131.2 million for FY2024, which is N/A changed from last year.
  • Day One Biopharmaceuticals' Revenue amounted to $39.8 million in Q3 2025, which was down 5755.7% from $33.9 million recorded in Q2 2025.
  • In the past 5 years, Day One Biopharmaceuticals' Revenue ranged from a high of $93.8 million in Q3 2024 and a low of $8.2 million during Q2 2024